Cardinal Health (NYSE:CAH) Sets New 1-Year High on Analyst Upgrade

Shares of Cardinal Health, Inc. (NYSE:CAH) hit a new 52-week high during trading on Thursday after Wells Fargo & Company raised their price target on the stock from $221.00 to $237.00. Wells Fargo & Company currently has an overweight rating on the stock. Cardinal Health traded as high as $214.93 and last traded at $214.43, with a volume of 103655 shares traded. The stock had previously closed at $213.56.

CAH has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft raised their price target on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. UBS Group raised their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Argus boosted their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Finally, Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $216.33.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent earnings and guidance support continued upside — Cardinal beat EPS and revenue last quarter and set FY‑2026 guidance of $9.65–$9.85, which underpins bullish analyst commentary and sentiment.
• Positive Sentiment: Analyst upgrade and higher price target — Wells Fargo raised its price target to $237 and kept an “overweight” rating, signaling institutional confidence and an ~11.6% upside vs. current levels. Wells Fargo raises PT to $237
• Positive Sentiment: Momentum: 52-week high and positive coverage — Zacks notes CAH reached a 52‑week high and highlights fundamentals that could sustain the run, supporting momentum traders. Cardinal Health Hit a 52 Week High
• Neutral Sentiment: Income/dividend profile noted — A TalkMarkets dividend analysis flags CAH as a major distributor with dividend appeal for income investors, but it’s not a near-term price catalyst. Dividend Stock Analysis: Cardinal Health, Inc.
• Neutral Sentiment: Multiple Zacks pieces highlight CAH for earnings-beat potential and strong interest coverage — useful context for investors but not an immediate trigger. Will Cardinal Beat Estimates Again?
• Neutral Sentiment: General market/quote pages note price action — coverage from Globe and Mail and Economic Times provides market/quote context but no new company developments. Analysts Offer Insights on Healthcare Companies
• Negative Sentiment: Profit-taking and valuation concerns pushing a pullback — after the 52‑week high and analyst hype, investors appear to be trimming positions; intraday volume is below average and the stock carries a relatively rich P/E (~32) and other metrics (negative trailing ROE) that may prompt caution.

Institutional Investors Weigh In On Cardinal Health

A number of large investors have recently added to or reduced their stakes in CAH. Vanguard Group Inc. grew its holdings in Cardinal Health by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 30,823,483 shares of the company’s stock valued at $4,838,054,000 after buying an additional 247,667 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after acquiring an additional 205,539 shares during the last quarter. Wellington Management Group LLP increased its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after acquiring an additional 3,511,579 shares during the period. Bank of America Corp DE increased its position in Cardinal Health by 3.2% during the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock worth $563,922,000 after acquiring an additional 111,582 shares during the period. Finally, Invesco Ltd. raised its stake in Cardinal Health by 14.7% during the 3rd quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after purchasing an additional 445,425 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.5%

The stock has a market capitalization of $50.48 billion, a P/E ratio of 32.04, a P/E/G ratio of 1.48 and a beta of 0.65. The business’s fifty day simple moving average is $205.37 and its two-hundred day simple moving average is $174.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.Cardinal Health’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s payout ratio is currently 30.77%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.